Supernus to pay $33.4M CVR milestone payment after Milestone 1 achieved March 18

SUPERNUS PHARMACEUTICALS, INC.

Milestone 1 under July 2025 CVR Agreement achieved on March 18, 2026; triggers $0.50 per CVR payment.
Aggregate milestone payment ~$33.4 million, payable in cash within 20 business days of May 17, 2026 Notice Date.
Company will deposit funds with Rights Agent Equiniti Trust Company for distribution to CVR holders.
CVRs were issued as part of prior business combination; this payment reduces future contingent liability.

item 2.03item 9.01

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.